Details of the Drug Excipient

General Information of Drug Inactive Ingredient (DIG) (ID: E00061)

• DIG Name: Cetyl alcohol
• Synonyms: 1-Hexadecanol; cetyl alcohol; Hexadecan-1-ol; 36653-82-4; HEXADECANOL; Cetanol; Palmityl alcohol; Hexadecyl alcohol; n-Cetyl alcohol; Cetaffine; Cetylol; Cetal; Ethal; Ethol; Cetylic alcohol; N-Hexadecanol; n-Hexadecyl alcohol; n-1-Hexadecanol; Loxanwachs SK; Crodacol C; Loxanol K extra; 1-Hexadecyl alcohol; Elfacos C; Loxanol K; Crodacol-CAS; Crodacol-CAT; Siponol wax-A; Atalco C; Cetalol CA; Siponol CC; Lanol C; 1-Cetanol; Hyfatol 16; Cachalot C-50; Cachalot C-51; Cachalot C-52; Alcohol C-16; Product 308; Aldol 54; Dytol F-11; Adol; Cyclal cetyl alcohol; Alfol 16; Lorol 24; Adol 52; Adol 54; Adol 52 NF; Hyfatol; Epal 16NF; 1-Hexadecyl alc; 16-Hexadecanol; C16 alcohol; Adol 520; n-Hexadecan-1-ol; Cetylalkohol; Isocetyl alcohol; 1-Hexanedecanol; Isohexadecyl alcohol; cetylalcohol; SSD RP; Normal primary hexadecyl alcohol; Alcohols, C14-18; CO-1670; CO-1695; Lipocol C; UNII-936JST6JCN; Fancol CA; Cetyl alcohol NF; Crodacol C70; Rita CA; 1-Hydroxyhexadecane; Cetanol (TN); Lanette 16; Philcohol 1600; Cetyl alcohol (NF); Cetyl alcohol [NF]; Lorol C16; LorolL 24; Cachalot C-50 NF; Adol 52NF; MFCD00004760; 936JST6JCN; CHEBI:16125; NSC4194; NCGC00159368-02; NCGC00159368-05; 1-Hexadecanol, 96%; palmitic alcohol; 1-Hexadecan-d33-ol; DSSTox_CID_7991; DSSTox_RID_78633; DSSTox_GSID_27991; Hexadecanol (VAN); Fatty alcohol(C16); Caswell No. 165D; FEMA Number 2554; Hexadecyl alcohol, normal; CAS-36653-82-4; FEMA No. 2554; HSDB 2643; NSC 4194; EINECS 253-149-0; EPA Pesticide Chemical Code 001508; Cetyl alcohol (hexadecanol); BRN 1748475; hexadecylalcohol; AI3-00755; Hexadecanol NF; Ceraphyl ICA; Crodacol C95NF; Dehydag wax 16; Eutanol G16; Crodacol C95 NF; Laurex 16; Alfol 16RD; hexadecan-1-ol group; SSD (Salt/Mix); Cetanol (JP17); Epal 16; Hyfatol 16-95; Kalcol 6098; Loxiol VPG 1743; 1-Hexadecanol, 95%; ACMC-1AJXA; SSD RP (Salt/Mix); CCCCCCCCCCCCCCCC[O]; bmse000487; CHEMBL706; Michel XO-150-16; EC 253-149-0; 1-Hexadecanol, >=99%; SCHEMBL3381; 124-29-8; 4-01-00-01876 (Beilstein Handbook Reference); ARONIS25150; DTXSID4027991; AMY6070; Cetyl alcohol, analytical standard; Cetyl alcohol, puriss., 95.0%; HMS3652H05; CS-D1348; HY-B1465; NSC-4194; ZINC8214519; EINECS 252-964-9; Tox21_111609; Tox21_300325; ANW-28459; LMFA05000061; s4173; SBB060167; STL283943; AKOS005287456; Tox21_111609_1; 1-Hexadecanol, ReagentPlus(R), 99%; CCG-266894; DB09494; MCULE-9457426256; NE10353; NCGC00159368-03; NCGC00159368-04; NCGC00159368-06; NCGC00254286-01; BS-16666; ST075158; Cetyl alcohol, puriss., >=99.0% (GC); FT-0701357; FT-0707360; N-HEXADECYL-16,16,16-D3 ALCOHOL; SW219201-1; Cetyl alcohol, SAJ special grade, >=98.0%; Cetyl alcohol, Selectophore(TM), >=99.0%; EN300-19351; 1-Hexadecanol, Vetec(TM) reagent grade, 94%; C00823; D00099; AB01566915_01; Q161632; SR-01000944409; SR-01000944409-1; 810F139F-C57E-4DF1-916A-A320AD0DAF4D; F0001-1047; N-HEXADECANOL (2,2,3,3...16,16,16-D31); UNII-13F4MW8Y9K component BXWNKGSJHAJOGX-UHFFFAOYSA-N; UNII-2DMT128M1S component BXWNKGSJHAJOGX-UHFFFAOYSA-N; UNII-B1K89384RJ component BXWNKGSJHAJOGX-UHFFFAOYSA-N; UNII-S4827SZE3L component BXWNKGSJHAJOGX-UHFFFAOYSA-N; UNII-U0T8J52I8B component BXWNKGSJHAJOGX-UHFFFAOYSA-N; Cetyl alcohol, European Pharmacopoeia (EP) Reference Standard; Cetyl alcohol, United States Pharmacopeia (USP) Reference Standard; Cetyl Alcohol, Pharmaceutical Secondary Standard; Certified Reference Material; 203633-15-2; 75736-52-6
• DIG Function: Coating agent; Emollient; Emulsifying agent; Stiffening agent
• Formula: C16H34O
• Canonical SMILES: CCCCCCCCCCCCCCCCO
• InChI: 1S/C16H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h17H,2-16H2,1H3
• InChIKey: BXWNKGSJHAJOGX-UHFFFAOYSA-N
• Physicochemical Properties:
  Molecular Weight; 242.44; Topological Polar Surface Area; 20.2
  XlogP; 7.3; Complexity; 123
  Heavy Atom Count; 17; Rotatable Bond Count; 14
  Hydrogen Bond Donor Count; 1; Hydrogen Bond Acceptor Count; 1

Full List of Drug(s) Co-administrated with This DIG

19 Approved Drug(s) Co-administrated with This DIG

Drug Name	Drug ID	Indication	Formulation Name	Formulation ID
Betamethasone	DMAHJEF	Acute adrenal insufficiency []	Betamethasone Valerate 0.1% cream	F23647
Budesonide	DMJIBAW	Allergic rhinitis [CA08.0]	Budesonide 3 mg capsule	F02734
Ciclopirox	DMN5T2A	Cutaneous candidiasis [1F23.14]	Ciclopirox 0.77% cream	F23683
Clascoterone	DMPGR1E	Acne vulgaris [ED80]	Clascoterone 1% cream	F23117
Clotrimazole	DMMFCIH	Cutaneous candidiasis [1F23.14]	Clotrimazole eq 0.05% base cream	F24431
Desonide	DMTP2NJ	Allergic rhinitis [CA08.0]	Desonide 0.05% lotion	F23703
Dextroamphetamine	DMMIHVP	Attention deficit hyperactivity disorder [6A05.Z]	Dextroamphetamine 10 mg capsule	F05584
Diclofenac	DMPIHLS	Chronic renal failure [GB61.Z]	Diclofenac 100 mg tablet	F05719
Fluocinolone Acetonide	DMG2KI4	Choroiditis []	Fluocinolone Acetonide 0.01% ointment	F23747
Flurandrenolide	DMHCI9S	Exanthem []	Flurandrenolide 0.05% cream	F23172
Halcinonide	DMGLAX1	Exanthem []	Halcinonide 0.1% cream	F23763
Halobetasol Propionate	DM3GB6S	Inflammation [1A00-CA43.1]	Halobetasol Propionate 0.05% lotion	F23768
Methylphenidate	DM7SJD6	Attention deficit hyperactivity disorder [6A05.Z]	Methylphenidate 20 mg tablet	F13568
Mupirocin	DMWX683	Bacterial infection [1A00-1C4Z]	Mupirocin eq 2% base cream	F23827
Omeprazole	DM471KJ	Cystic fibrosis [CA25]	Omeprazole 10 mg capsule	F15818
Permethrin	DMZ0Q1G	Pediculus capitis infestation [1G00.0]	Permethrin 1% lotion	F23867
Sulfacetamide	DMZ6VEY	Acne vulgaris [ED80]	Sulfacetamide 10% cream	F23909
Terconazole	DMJ13KI	Candidiasis [1F23]	Terconazole 0.4% cream	F23916
Ursodeoxycholic acid	DMCUT21	Cholelithiasis [DC11]	Ursodeoxycholic acid 250 mg tablet	F21747

1 Clinical Trial Drug(s) Co-administrated with This DIG

Drug Name	Drug ID	Indication	Formulation Name	Formulation ID
Impoyz	DMB1N6P	Scalp dermatosis []	Clobetasol Propionate 0.05% aerosol	F23047